| __timestamp | Arrowhead Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 4473654 |
| Thursday, January 1, 2015 | 34718089 | 8597010 |
| Friday, January 1, 2016 | 40998209 | 7910260 |
| Sunday, January 1, 2017 | 32022880 | 7304399 |
| Monday, January 1, 2018 | 19110051 | 15875961 |
| Tuesday, January 1, 2019 | 26556257 | 36881187 |
| Wednesday, January 1, 2020 | 52275890 | 44233754 |
| Friday, January 1, 2021 | 80981000 | 49628000 |
| Saturday, January 1, 2022 | 124431000 | 58183000 |
| Sunday, January 1, 2023 | 90932000 | 133710000 |
| Monday, January 1, 2024 | 98761000 |
Cracking the code
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Catalyst Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. have showcased distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Arrowhead's SG&A expenses surged by approximately 300%, peaking in 2022. In contrast, Catalyst's expenses saw a dramatic increase of nearly 2,900% by 2023, highlighting a strategic shift in their operational focus.
These trends reflect broader industry dynamics, where companies balance cost management with growth strategies. Missing data for 2024 suggests ongoing developments, making this a space to watch.
Comparing SG&A Expenses: Genmab A/S vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Neurocrine Biosciences, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Mesoblast Limited
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE